Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

MCPIP1 suppresses hepatitis C virus replication and negatively regulates virus-induced proinflammatory cytokine responses.

Lin RJ, Chu JS, Chien HL, Tseng CH, Ko PC, Mei YY, Tang WC, Kao YT, Cheng HY, Liang YC, Lin SY.

J Immunol. 2014 Oct 15;193(8):4159-68. doi: 10.4049/jimmunol.1400337. Epub 2014 Sep 15.

2.

MCPIP1 ribonuclease exhibits broad-spectrum antiviral effects through viral RNA binding and degradation.

Lin RJ, Chien HL, Lin SY, Chang BL, Yu HP, Tang WC, Lin YL.

Nucleic Acids Res. 2013 Mar 1;41(5):3314-26. doi: 10.1093/nar/gkt019. Epub 2013 Jan 25.

3.

Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.

Moschen AR, Fritz T, Clouston AD, Rebhan I, Bauhofer O, Barrie HD, Powell EE, Kim SH, Dinarello CA, Bartenschlager R, Jonsson JR, Tilg H.

Hepatology. 2011 Jun;53(6):1819-29. doi: 10.1002/hep.24285. Epub 2011 May 14.

PMID:
21381070
4.

MCPIP1 inhibits coxsackievirus B3 replication by targeting viral RNA and negatively regulates virus-induced inflammation.

Li M, Yan K, Wei L, Yang Y, Qian Q, Xu W.

Med Microbiol Immunol. 2018 Feb;207(1):27-38. doi: 10.1007/s00430-017-0523-0. Epub 2017 Oct 17.

PMID:
29043433
5.

Relationships between hepatitis C virus replication and CXCL-8 production in vitro.

Koo BC, McPoland P, Wagoner JP, Kane OJ, Lohmann V, Polyak SJ.

J Virol. 2006 Aug;80(16):7885-93.

6.

Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.

Plumlee CR, Lazaro CA, Fausto N, Polyak SJ.

Virol J. 2005 Dec 2;2:89.

7.

An immunosuppressive function of interleukin-35 in chronic hepatitis C virus infection.

Liu S, Zhang Q, Shao X, Wang W, Zhang C, Jin Z.

Int Immunopharmacol. 2017 Sep;50:87-94. doi: 10.1016/j.intimp.2017.06.015. Epub 2017 Jun 20.

PMID:
28644966
8.
9.

Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis.

Sarma NJ, Tiriveedhi V, Crippin JS, Chapman WC, Mohanakumar T.

J Virol. 2014 Apr;88(7):3733-43. doi: 10.1128/JVI.03060-13. Epub 2014 Jan 15.

10.

Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner.

Shao RX, Zhang L, Peng LF, Sun E, Chung WJ, Jang JY, Tsai WL, Hyppolite G, Chung RT.

J Virol. 2010 Jun;84(12):6060-9. doi: 10.1128/JVI.02484-09. Epub 2010 Apr 7.

11.

Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies.

Larrea E, Aldabe R, Molano E, Fernandez-Rodriguez CM, Ametzazurra A, Civeira MP, Prieto J.

Gut. 2006 Aug;55(8):1188-96. Epub 2005 Aug 24.

12.

Hepatitis C virus (HCV) induces formation of stress granules whose proteins regulate HCV RNA replication and virus assembly and egress.

Garaigorta U, Heim MH, Boyd B, Wieland S, Chisari FV.

J Virol. 2012 Oct;86(20):11043-56. Epub 2012 Aug 1.

13.

[Effect of Hepatitis C virus proteins on the production of proinflammatory and profibrotic cytokines in Huh7.5 human hepatoma cells].

Masalova OV, Lesnova EI, Permyakova KY, Samokhvalov EI, Ivanov AV, Kochetkov SN, Kushch AA.

Mol Biol (Mosk). 2016 May-Jun;50(3):486-95. doi: 10.7868/S0026898416020166. Russian.

14.

Y-Box Binding Protein 1 Stabilizes Hepatitis C Virus NS5A via Phosphorylation-Mediated Interaction with NS5A To Regulate Viral Propagation.

Wang WT, Tsai TY, Chao CH, Lai BY, Wu Lee YH.

J Virol. 2015 Nov;89(22):11584-602. doi: 10.1128/JVI.01513-15. Epub 2015 Sep 9.

15.

SYNCRIP (synaptotagmin-binding, cytoplasmic RNA-interacting protein) is a host factor involved in hepatitis C virus RNA replication.

Liu HM, Aizaki H, Choi KS, Machida K, Ou JJ, Lai MM.

Virology. 2009 Apr 10;386(2):249-56. doi: 10.1016/j.virol.2009.01.018. Epub 2009 Feb 20.

17.

A host cell RNA-binding protein, Staufen1, has a role in hepatitis C virus replication before virus assembly.

Blackham SL, McGarvey MJ.

J Gen Virol. 2013 Nov;94(Pt 11):2429-36. doi: 10.1099/vir.0.051383-0. Epub 2013 Aug 1.

PMID:
23907398
18.

Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology.

Ng TI, Mo H, Pilot-Matias T, He Y, Koev G, Krishnan P, Mondal R, Pithawalla R, He W, Dekhtyar T, Packer J, Schurdak M, Molla A.

Hepatology. 2007 Jun;45(6):1413-21.

PMID:
17518369
19.

Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells.

Frentzen A, Anggakusuma, Gürlevik E, Hueging K, Knocke S, Ginkel C, Brown RJ, Heim M, Dill MT, Kröger A, Kalinke U, Kaderali L, Kuehnel F, Pietschmann T.

Hepatology. 2014 Jan;59(1):78-88. doi: 10.1002/hep.26626. Epub 2013 Nov 18.

PMID:
23873628
20.

Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection.

Bocchetta S, Maillard P, Yamamoto M, Gondeau C, Douam F, Lebreton S, Lagaye S, Pol S, Helle F, Plengpanich W, Guérin M, Bourgine M, Michel ML, Lavillette D, Roingeard P, le Goff W, Budkowska A.

PLoS One. 2014 Mar 19;9(3):e92140. doi: 10.1371/journal.pone.0092140. eCollection 2014.

Supplemental Content

Support Center